Latest Prophylaxis Stories
SCHAUMBURG, Ill., July 1 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's nine presentations of heparin sodium injection, USP.
CHICAGO, May 26 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc.
Hepatocellular carcinoma (HCC) is the most common primary neoplasm of the liver and often arises in the context of a chronic liver disease that impairs coagulative function.
BOSTON, Jan. 19 /PRNewswire/ -- The North American Thrombosis Forum (NATF), in coordination with Eisai Inc., announced today that three hospitals have been selected as recipients of the 2009 DVTeamCare Hospital Award.
VOORHEES, N.J., Oct. 22 /PRNewswire/ -- Hereditary angioedema (HAE) is an autosomal dominant disease estimated to afflict between 1 in 10,000 to 1 in 50,000 people in the United States.
Infective endocarditis (IE) is a severe form of valve disease characterized by infection located in the valves of the heart. It is still associated with a high mortality (10-26% in-hospital mortality).
BRIDGEWATER, N.J., Aug. 17 /PRNewswire-FirstCall/ -- Sanofi-aventis U.S.
According to a study in a special issue of Medical Decision Making, a large-scale, covert anthrax attack on a large city would overwhelm hospital resources even with an extremely effective public health response, primarily because of expected delays in detecting the attack and initiating a response to it.
Surgical gloves that develop holes or leaks during a procedure appear to increase the risk of infection at the surgical site among patients who are not given antibiotics beforehand, according to a report in the June issue of Archives of Surgery, one of the JAMA/Archives journals.
ANNAPOLIS, Md., June 2 /PRNewswire-FirstCall/ -- PharmAthene, Inc.